Menu

Recent Interviews

Lewis Black, CEO, Almonty Industries

Lewis Black
CEO | Almonty Industries
100 King Street West, M5X 1C7 Toronto (CAN)

info@almonty.com

+1 (647) 438-9766

Interview with mine operator Almonty Industries: "Tungsten makes e-cars better"


Nick Luksha, President, Prospect Ridge Resources

Nick Luksha
President | Prospect Ridge Resources
1288 West Cordova Street Suite 2807, V6C 3R3 Vancouver (CAN)

info@prospectridgeresources.com

Interview Prospect Ridge Resources: These fillets taste good to the market


Dirk Graszt, CEO, Clean Logistics SE

Dirk Graszt
CEO | Clean Logistics SE
Trettaustr.32, 21107 Hamburg (DE)

info@cleanlogistics.de

+49-4171-6791300

Interview Clean Logistics: Hydrogen challenge to Daimler + Co.


26. October 2021 | 11:37 CET

Tilray, Ayurcann, Aurora Cannabis, Canopy Growth - Sow first, then reap

  • Cannabis
Photo credits: pixabay.com

After the hype around cannabis companies like Aurora Cannabis, Tilray and Canopy Growth in 2018, consolidation followed, and it continues. But the industry is moving mightily. Smaller companies disappeared from the price list, while big players expanded their market power through mergers and acquisitions for the next few years. The cannabis industry is predicted to grow tremendously in the future. The fantasy is fueled by government legalization plans in several states, including Germany.

time to read: 3 minutes by Stefan Feulner
ISIN: TILRAY INC. CL.2 DL-_0001 | US88688T1007 , AYURCANN HOLDINGS CORP | CA05476A1012 , AURORA CANNABIS | CA05156X8843 , CANOPY GROWTH | CA1380351009


 

Author

Stefan Feulner

The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
He is passionate about analyzing a wide variety of business models and investigating new trends.

About the author


Canada as legalization pioneer

While Scholz, Habeck and Lindner are negotiating the next steps regarding the legalization of cannabis, among other things, during talks on the traffic light coalition, the intoxicant has already been legal in Canada since 2018. Even before legalization, Canada was the country with the most cannabis users in the world. A quarter of the population regularly consumes hashish, marijuana or cannabis-infused edibles recreationally or for medical reasons. According to Stats Canada and Equity Research, the Canadian legal cannabis market was worth USD 3.1 billion in 2020 and is expected to triple to USD 10.1 billion by 2025. The global legal cannabis market is expected to grow up to USD 66.3 billion during the same period.

The reasons for the vast growth rates can be explained in the broader product range. In 2018, legal consumption was limited only to flowers, oils, plants and seeds. A year later, Cannabis 2.0. took the next step and expanded for over-the-counter marijuana to include cannabis derivatives, including beverages, edibles, e-cigarettes, and so-called vapes. With the emerging third wave, the billion-dollar healthcare sector, in particular, is now to be fed with cannabis products. Here, bath products, skincare creams and lotions, and ointments are increasingly hitting store shelves.

White label the solution

For smaller cannabis companies, the expansion of the product range is becoming an ever-greater challenge and cannot be managed alone for reasons of cost, capacity and licensing. White labeling, which is becoming more prevalent in the industry, allows companies to focus on establishing their brand and accelerating the expansion of their product line without investing in infrastructure, processing labs, and production facilities required to manufacture these products.

The manufacturing of each product will be handled by one of the leading B2B post-harvest solutions providers, Ayurcann, which focuses on providing scalable custom processes and pharmaceutical-grade products to Canada's recreational and medical cannabis industries. In doing so, customers can choose from 40 products ranging from creams to vape pens to balms developed by Ayurcann and bring them to market under their brand. It is subject to a flat fee or a percentage of product sales. More than 20 customers are currently using the white-label services, including the Israeli companies Bazelet, Fuego and Vida or the US company Green Bee, which specializes in women's products.

Enormous potential

In doing so, the Ontario-based licensed cannabis extraction company is focused on the Canadian market. It is seeking strategic partnerships with international brands to help them distribute in the North American country. The Company's operations are close to more than 200 cannabis producers, allowing for efficient product transportation. The Company has a 10,845-square-foot facility used for co-packing, white labeling and high-purity extract processing, and the production of proprietary oil distillates for Cannabis 2.0 and 3.0 products. The production capacity is 200,000 kg of biomass per year and is planned to be expanded to 300,000 kg due to increasing demand, which corresponds to 30,000 kg of distillate production.

Figures inspire

The quarterly figures of the debt-free Company already show the significant economies of scale. Net sales for the third quarter of 2021 increased 67% quarter-on-quarter to USD 2.6 million, with an adjusted EBITDA of USD 1.1 million. Sales of the Company's oil distillates were the primary revenue driver, accounting for 84% of the total with a gross margin of around 35%. In comparison, the fast-growing white label business contributed 16% of revenue with a margin of 60%. Further increases are expected in the fourth quarter. Ayurcann's stock price in Frankfurt is currently EUR 0.12. The analyst firm Fundamental Research Corp. sees the Company as a buy candidate with a price target of the equivalent of EUR 0.49.

Anticyclical positioning

Despite a brief flare-up of euphoria and sharply rising prices, the price increases were used again to sell-off at the end of the week in cannabis stocks. The market is currently not yet at the end of the correction. In the long term, the segment should again be one of the winners. Due to this, the current correction offers an anti-cyclical entry in the big players such as Canopy Growth, Tilray and Aurora Cannabis. For all three stocks, the setback potential is between 10 and 15%.


With legalization plans in several states and the expansion of products to Cannabis 3.0. the industry should face a prosperous future in the long run. In addition to the Big Three mentioned above, Ayurcann is attractive due to its market leadership in white label solutions.


Author

Stefan Feulner

The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
He is passionate about analyzing a wide variety of business models and investigating new trends.

About the author



Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold long or short positions in the aforementioned companies and that there may therefore be a conflict of interest. Apaton Finance GmbH may have a paid contractual relationship with the company, which is reported on in the context of the Apaton Finance GmbH Internet offer as well as in the social media, on partner sites or in e-mail messages. Further details can be found in our Conflict of Interest & Risk Disclosure.


Related comments:

19. November 2021 | 13:13 CET | by Carsten Mainitz

Sativa Wellness Group, Aurora Cannabis, TUI - Rising consumer spending on wellness and travel

  • Cannabis

According to Statista, the health and wellness market is worth around EUR 105 billion. More than USD 900 billion is spent annually worldwide on beauty and antiaging alone. Spending on travel is also increasing significantly after a sharp drop in the wake of the Corona pandemic. Reason enough to take a look at three stocks of industry representatives. Who is making the running?

Read

11. November 2021 | 13:02 CET | by Fabian Lorenz

Bayer, TUI, Sativa Wellness: Figures move share prices

  • Cannabis

The reporting season is drawing to a close. Overall, most companies have been convincing, and the stock markets have been very friendly in recent weeks. Bayer published positive quarterly figures, raised its forecast for the full year and thus convinced the analysts from DZ Bank. Sativa Wellness benefits from the boom around cannabis and CBD. The still-new boom is growing strongly and is already in the black. At TUI, the operating figures play less of a role. The development of the Corona figures and, thus, possible travel restrictions in the coming winter are more critical. Read more about all three shares here.

Read

28. October 2021 | 12:04 CET | by André Will-Laudien

Canopy, Tilray, Sativa Wellness, Formycon - Finding the next cannabis rocket!

  • Cannabis

The big bull market in cannabis ran through 2018 and 2019, and then in 2020, the reality set in that only a fraction of states around the world will implement general licensing for hemp. The newly elected federal parliament has its first constituent session these days. Climate change and investments in digital infrastructure are two of the most important topics in the coalition negotiations to form a new federal government. One topic that is not quite so high on the list of priorities, but is already causing a lot of excitement in the run-up, is the possible legalization of cannabis. The Greens and FDP have been advocating legal, regulated trade for some time. Of course, nothing has been decided yet, but the outgoing federal government's drug commissioner, Daniela Ludwig of the CSU, already warns of the consequences. We take a look at important industry representatives.

Read